Ginkgo Bioworks partners with Boehringer Ingelheim to develop breakthrough therapies
Ginkgo Bioworks, a platform for cell programming and biosecurity, has announced a new partnership with Boehringer Ingelheim.
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ginkgo Bioworks, a platform for cell programming and biosecurity, has announced a new partnership with Boehringer Ingelheim.
Lonza has launched the Nebula Absorbance Reader, a new absorbance microplate reader, which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.
Evox Therapeutics, an exosome therapeutics company, has announced the publication of its research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes.
Terumo Blood and Cell Technologies have announced US Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System.
A promising shift towards the development of antibody-drug conjugates (ADC) for cancer treatment is taking place in the pharmaceutical industry.